New twice-yearly drug prompting hopes of curbing HIV cases
Season 2025
Episode 182
About the Episode
The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But deep cuts to health initiatives could hinder the rollout. Lenacapavir not only offers nearly 100 percent protection from HIV, but people only need two injections per year. William Brangham discussed more with Mitchell Warren of the AIDS Vaccine Advocacy Coalition.
Aired:
| Expires: | Runtime: 7m 17s
Recent Episodes
Extras
-
Search for justice continues for Argentina’s disappeared
Search for justice continues for Argentina’s disappeared, nearly 50 years later7:50 -
News Wrap: Trump announces 30% tariffs on Mexico and EU
News Wrap: Trump announces 30% tariffs on goods from Mexico and EU2:17 -
New analysis reveals FEMA missed major flood risks in Texas
FEMA missed major flood risks at Camp Mystic in Texas, new analysis reveals5:18 -
NIH funding cuts threaten research on sickle cell disease
Trump administration’s NIH funding cuts threaten research on sickle cell disease5:23 -
Moo Deng, baby hippo who took social media by storm, turns 1
Moo Deng, the baby hippo who took social media by storm, turns 12:45 -
Trump tours catastrophic flood damage in central Texas
Trump tours catastrophic flood damage in central Texas, defends state and federal response2:55 -
News Wrap: State Department lays off more than 1,300
News Wrap: State Department lays off more than 1,300 in latest cuts to federal workforce6:01 -
Grieving daughter says mother’s death in flood was avoidable
Grieving daughter says mother’s death in Texas flood was avoidable10:32 -
How the toy industry is facing Trump's tariffs
How the toy industry is feeling the effects of Trump's tariffs6:20 -
PKK begins disarming in step toward peace with Turkey
After decades of insurgency against Turkey, PKK begins disarming in step toward peace9:17
